 Antony Waste Handling Cell Ltd Q2 FY2026 consolidated net profit down QoQ to Rs. 13.65 crores
Antony Waste Handling Cell Ltd Q2 FY2026 consolidated net profit down QoQ to Rs. 13.65 crores Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore
Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores
LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26
Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26 Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores
Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores 
              Morepen Laboratories Ltd has announced that in furtherance to the implementation of the CDR Package the Board of Directors of the Company at its meeting held on March 31, 2007 has revisited in detail the Investment proposals and reviewed the compliances made in this regard. The following decisions were taken in the Board Meeting;
1. The investment proposal of Avenue Asia Fund, in view of the need to adhere to the timelines drawn, not to be proceeded with.
2. The Board approved the issuance of upto 2,44,90,000 Equity Shares and 5,36,50,000 Warrants with rights attached to subscribe to equity shares, to new investors, existing bankers / Financial Institutions and Promoters at a price of Rs 20/- only which is a price based on SEBI formula, subject to the Shareholders approval.
3. The Shareholders approval be sought by convening the Extra Ordinary General Meeting.